Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis
2003 ◽
Vol 78
(1)
◽
pp. 56-61
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 60
(3)
◽
pp. 703-710
◽
Keyword(s):
Keyword(s):
1995 ◽
Vol 270
(30)
◽
pp. 17908-17912
◽
Keyword(s):